Monitoring the homogeneity of adenovirus preparations (a gene therapy delivery system) using analytical ultracentrifugation

Analytical Biochemistry

Volumn 362, Issue 1, 2007, Pages 16-37

  Berkowitz, Steven A ^a   Philo, John S ^b  

^a BIOGEN   (United States)

^b ALLIANCE PROTEIN LABORATORIES   (United States)

Author keywords

Adenovirus; Aggregation; Analytical ultracentrifugation; Empty capsids; Gene therapy

Indexed keywords

AGGLOMERATION; CENTRIFUGATION; CESIUM COMPOUNDS; CHLORINE COMPOUNDS; LIGHT SCATTERING; SEDIMENTATION;

ADENOVIRUS; ANALYTICAL ULTRACENTRIFUGATION; EMPTY CAPSIDS; PRODUCT FORMULATION; REFRACTOMETRIC DETECTIONS; SCATTERING EFFECTS; SEDIMENTATION EQUILIBRIUM; SEDIMENTATION VELOCITIES;

GENE THERAPY;

ADENOVIRUS VECTOR; CESIUM CHLORIDE;

ADENOVIRUS; AREA UNDER THE CURVE; ARTICLE; INTERFEROMETER; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL; REFRACTOMETRY; REPRODUCIBILITY; SEDIMENTATION RATE; ULTRACENTRIFUGATION; VIRAL GENE THERAPY; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS PARTICLE;

ADENOVIRIDAE; MIRIDAE;

EID: 33846667152     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.11.031     Document Type: Article

References (134)

1. Miller A.D. Human gene therapy comes of age. Nature 357 (1992) 455-460
2. Pfeifer A., and Verma I.M. Gene therapy: promise and problems. Annu. Rev. Genomics Hum. Genet. 2 (2001) 177-211
3. Gridley J.N., and Ogden J.E. The biopharmaceutical industry: future promise. In: Gridley J.N., and Ogden J.E. (Eds). Understanding Biopharmaceuticals: Manufacturing and Regulatory Issues (2000), Interpharm Press, Denver 270-272
4. Verm I.M., and Weitzman M.D. Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 74 (2005) 711-738
5. Peng Z. Current status of Gendicine in China: recombinant human Ad-p53 agent for treatment of cancer. Hum. Gene Ther. 16 (2005) 1016-1027
6. Hitt M.M., Addison C.L., and Graham F.L. Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40 (1997) 137-206
7. Zhang W.-W. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 6 (1999) 113-138
8. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 81 (2000) 2573-2604
9. Volpers C., and Kochanek S. Adenoviral vectors for gene transfer and therapy. J. Gene Med. 6 (2004) S164-S171
10. McConnell M.J., and Imperiale M.J. Biology of adenovirus and its use as a vector for gene therapy. Hum. Gene Ther. 15 (2004) 1022-1033
11. Lee C.-J., Lee L.H., and Lu C.-H. Development and Evaluation of Drugs: From Laboratory Through Licensure to Market (2003), CRC Press, New York pp. 23-116
12. Roitsch C., Achstetter T., Benchaibi M., Bonfils E., Cauet G., Gloeckler R., L'hote H., Keppi E., Nguyen M., Spehner D., Van Dorsselaer A., and Malarme D. Characterization and quality control of recombinant adenovirus vectors for gene therapy. J. Chromatogr. B 752 (2001) 263-280
13. Lusky M. Good manufacturing practice production of adenoviral vectors for clinical trials. Hum. Gene Ther. 16 (2005) 281-291
14. Gombold J., Peden K., Gavin D., Wei Z., Baradaran K., Mire-Sluis A., and Schenerman M. Lot release and characterization testing of live-virus-based vaccines and gene therapy products, part I. BioProcessing Int. 4 (2006) 46-51
15. Gombold J., Peden K., Gavin D., Wei Z., Baradaran K., Mire-Sluis A., and Schenerman M. Lot release and characterization testing of live-virus-based vaccines and gene therapy products, part II. BioProcessing Int. 4 (2006) 55-65
16. Bondoc L.L., and Fitzpatrick S. Size distribution analysis of recombinant adenovirus using disc centrifugation. J. Ind. Microbiol. Biotechnol. 20 (1998) 317-322
17. Hutchins B. Development of a reference material for characterizing adenovirus vectors. BioProcessing J. 1 (2002) 25-28
18. Rexroad J., Evans R.K., and Middaugh C.R. Effect of ionic strength on the physical stability of adenovirus type 5. J. Pharm. Sci. 95 (2006) 237-247
19. Konz J.O., Lee A.L., Lewis J.A., and Sagar S.L. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA. Biotechnol. Prog. 21 (2005) 466-472
20. Rexroad J., Wiethoff C.M., Green A.P., Kierstead T.D., Scott M.O., and Middaugh C.R. Structural stability of adenovius type 5. J. Pharm. Sci. 92 (2002) 665-678
21. Adadevoh K., Croyle M., Malarme D., Bonfils E., and Bowe M.A. A short-term field use and shipping stability study of a wild type Ad5 adenoviral reference material. BioProcessing J. 1 (2002) 62-69
22. J. Smith, M. Menger, M. Carrion, B.T. Butman, A dynamic light scattering (DLS) assay for the analysis of aggregated adenovector particles, in: 6th Annual Meeting of the American Society of Gene Therapy, June 4-8 (2003) abstract #519, Mol. Ther. 7 (2003) S199.
23. S. Berkowitz, J. Philo, Limitations and advantages in assessing adenovirus homogeneity by laser light scattering and analytical ultracentrifugation: measuring the aggregation of large biopharmaceuticals, presented at the "WCBP 2003: 7th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products," held by the California Separation Science Society in San Francisco, CA on January 7-10, 2003. .
24. Obenauer-Kutner L.J., Ihnat P.M., Yang T.-Y., Dovey-Hartman B.J., Balu A., Cullen C., Bordens R.W., and Grace M.J. The use of field emission scanning electron microscopy to assess recombinant adenovirus stability. Hum. Gene Ther. 13 (2002) 1687-1696
25. Obenauer-Kutner L.J., Halperin R., Ihnat P.M., Tully C.P., Borden R.W., and Grace M.J. Use of an automated image processing program to quantify recombinant adenovirus particles. Microsc. Microanal. 11 (2005) 37-41
26. Shabram P.W., Giroux D.D., Goudreau A.M., Gregory R.J., Horn M.T., Huyghe B.G., Liu X., Nunnally M.H., Sugarman B.J., and Sutjipto S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum. Gene Ther. 8 (1997) 453-465
27. Blanche F., Cameron B., Barbot A., Ferrero L., Guillemin T., Guyot S., Somarriba S., and Bisch D. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther. 7 (2000) 1055-1062
28. Transfiguracion J., Bernier A., Arcand N., Chahal P., and Kamen A. Validation of a High-performance liquid chromatographic assay for the quantification of adenovirus type 5 particles. J. Chromatogr. B 761 (2001) 187-194
29. Klyushnichenko V., Bernier A., Kamen A., and Harmsen E. Improved high-performance liquid chromatographic method in the analysis of adenovirus particles. J. Chromatogr. B 755 (2001) 27-36
30. Lehmberg E., Traina J.A., Chakel J.A., Chang R.-J., Parkma M., McCaman M.T., Murakami P.K., Lahidji V., Nelson J.W., Hancock W.S., Nestaas E., and Pungor Jr. E. Reverse-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome. J. Chromatogr. B 732 (1999) 411-423
31. Blanche F., Monegier B., Faucher D., Duchesne M., Audhuy F., Barbot A., Bouvier S., Daude G., Dubois H., Guillemin T., and Maton L. Polypeptide composition of an adenovirus type 5 used in cancer gene therapy. J. Chromatogr. A 921 (2001) 39-48
32. B. Mann, E. Zimmermann, J. Traina, E. Pungor, Determination of aggregation in adenovirus preparations by capillary zone electrophoresis and field flow fractionation, presented at the "CE in Biotechnology Industries: Practical Applications for the Analysis of Proteins, Nucleotides and small molecules" meeting, held by the California Separation Science Society in Washington, DC, on August 17-19, 2002. .
33. Application note from Wyatt technology, Inc. "Adenovirus particle characterization".
34. Mann B., Traina J.A., Soderblom C., Murakami P.K., Lehmberg E., Lee D., Irving J., Nestaas E., and Pungor Jr. E. Capillary zone electrophoresis of a recombinant adenovirus. J. Chromatogr. A 895 (2000) 329-337
35. Vellekamp G., Porter F.W., Sutjipto S., Cutler C., Bondoc L., Liu Y.-H., Wylie D., Cannon-Carlson S., Tang J.T., Frei A., Voloch M., and Zhuang S. Empty capsid in column-purified recombinant adenovirus preparations. Hum. Gene Ther. 12 (2001) 1923-1936
36. Schachman H.K., and Williams R.C. Physical properties of infective particles. Viruses 1 (1959) 223-327
37. Philo J.S. Analytical ultracentrifugation. In: Jiskoot W., and Crommelin D. (Eds). Methods for Structural Analysis of Protein Pharmaceuticals (2005), AAPS Press 379-412
38. Berkowitz S.A. The role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals. AAPS J. 8 (2006) E590-E605
39. H.K. Schachman, Is there a future for the ultracentrifuge? in: S.E. Harding, A.J. Rowe, J.C. Horton (Eds.), Analytical Ultracentrifugation in Biochemistry and Polymer Science, Royal Society for Chemistry, Redwood Press, 1992, pp. 3-15.
40. Schachman H.K. Analytical ultracentrifugation reborn. Nature 341 (1989) 259-260
41. Ralston G. The renaissance of the analytical ultracentrifuge. Today's Life Sci. 3 (1991) 42-50
42. Harding S.E. Analytical ultracentrifugation and the genetic engineering of macromolecules. Biotechnol. Genet. Eng. Rev. 11 (1993) 317-356
43. Harding S.E. The analytical ultracentrifuge spins again. Trends Anal. Chem. 13 (1994) 439-446
44. Shire S.J. Analytical ultracentrifugation and its use in biotechnology. In: Schuster T.M., and Laue T.M. (Eds). Modern Analytical Ultracentrifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymers Systems (1994), Birkhauser, Boston 261-297
45. Schuster T.M., and Toedt J.M. New revolution in the evolution of analytical ultracentrifugation. Curr. Opin. Struct. Biol. 6 (1996) 650-658
46. Stafford W.F. Sedimentation velocity spins a new weave for an old fabric. Curr. Opin. Biotechnol. 8 (1997) 14-24
47. Liu J., and Shire S.J. Analytical ultracentrifugation in the pharmaceutical industry. J. Pharm. Sci. 88 (1999) 1237-1241
48. R. Giebeler, The Optima XL-A: a new analytical ultracentrifuge with a novel precision absorption optical system, in: S.E. Harding, A.J. Rowe, J.C. Horton (Eds.), Analytical Ultracentrifugation in Biochemistry and Polymer Science, Royal Society for Chemistry, Redwood Press, 1992, pp. 16-25.
49. Yphantis D.A., Lary J.W., Stafford W.F., Lui S., Olsen P.H., Hayes D.B., Moody T.P., Ridgeway T.M., Lyons D.A., and Laue T.M. On line data acquisition for the Rayleigh interference optical system of the analytical ultracentrifuge. In: Schuster T.M., and Laue T.M. (Eds). Modern Analytical Ultracentrifugation (1994), Birkhauser, Boston 209-226
50. Stafford III W.F. Boundary analysis in sedimentation transport experiments: A procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal. Biochem. 203 (1992) 295-301
51. Philo J.S. Measuring sedimentation, diffusion and molecular weight of small molecules by direct fitting of sedimentation velocity concentration profiles. In: Schuster T.M., and Laue T.M. (Eds). Modern Analytical Ultracentrifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymers Systems (1994), Birkhauser, Boston 156-170
52. Demeler B., Saber H., and Hansen J.C. Identification and interpretation of complexity in sedimentation velocity boundaries. Biophys. J. 72 (1997) 397-407
53. Demeler B., and Saber H. Determination of molecular parameters by fitting sedimentation data to finite element solutions of the Lamm equation. Biophys. J. 74 (1998) 444-454
54. Correia J.J. Sedimentation velocity analysis methods: what, when, why?. Chem. Tracts: Biochem. Mol. Biol. 11 (1998) 944-949
55. Stafford W. Analysis of reversibly interacting macromolecular systems by time derivative sedimentation velocity. Methods Enzymol. 323 (2000) 302-325
56. Schuck P. Sedimentation analysis of non-interacting and self-associating solutions using numerical solutions to the Lamm equation. Biophys. J. 75 (1998) 1503-1512
57. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78 (2000) 1606-1619
58. Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal. Biochem. 320 (2003) 104-124
59. Vistica J., Dam J., Balbo A., Yikilmaz E., Mariuzza R.A., Rouault T.A., and Schuck P. Sedimentation equilibrium analysis of protein interactions with global implicit mass conversation constraints and systematic noise decomposition. Anal. Biochem. 326 (2004) 234-256
60. Dam J., and Schuck P. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol. 384 (2004) 185-212
61. Schuck P. Diffusion-deconvoluted sedimentation coefficient distributions for the analysis of interacting and non-interacting protein mixtures. In: Scott D.J., Harding S.E., and Rowe A.J. (Eds). Analytical Ultracentrifugation: Techniques and Methods (2005), RSC Publishing, UK, Cambridge 26-50
62. Maizel Jr. J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus I. Evidence for multiple protein components in the virion and a comparison of type 2, 7A, and 12. Virology 36 (1968) 115-125
63. T.M. Laue, Choosing which optical system of the Optima XL-I analytical ultracentrifuge to use, Application information #A-1821A, Beckman/Coulter.
64. Laue T.M. Sedimentation as a thermodynamic tool. Methods Enzymol. 259 (1995) 427-452
65. Huyghe B.G., Lui X., Sutjipto S., Sugarman B.J., Horn M.T., Shepard H.M., Scandella C.J., and Shabram P. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther. 6 (1995) 1403-1416
66. Green A.P., Huang J.J., Scott M.O., Kierstead T.D., Beaupre I., Gao G.-P., and Wilson J.M. A new Scalable method for the purification of recombinant adenovirus vectors. Hum. Gene Ther. 13 (2002) 1921-1934
67. Burlingham B.T., Brown D.T., and Doerfler W. In complete particles of adenovirus I. Characterizations of DNA associated with incomplete adenovirions of type 2 and 12. Virology 60 (1974) 419-430
68. Daniell E. Genome structure of incomplete particles of adenovirus. J. Virol. 19 (1976) 685-708
69. Valentine R.C., and Hopper P.K. Polyhedral shape of adenovirus particles as shown by electron microscopy. Nature 180 (1957) 928
70. S.B. Dubin, Ph.D, Thesis, Massachusetts Institute of Technology, Cambridge, MA, 1970.
71. Ruigrok R.W.H., Barge A., Albiges-Rizo C., and Dayan S. Structure of adenovirus fibre. II. Morphology of single fibres. J. Mol. Biol. 215 (1990) 589-596
72. J. Garcia De La Torre, Sedimentation coefficient of complex biological particles, in: S.E. Harding, A.J. Rowe, J.C. Horton (Eds.), Analytical Ultracentrifugation in Biochemistry and Polymer Science, Royal Society for Chemistry, Redwood Press, Cambridge, UK, 1992, pp. 333-345.
73. Oliver C.J., Shortridge K.F., and Belyavin G. Diffusion coefficient and molecular weight of type 5 adenovirus by photon-correlation spectroscopy. Biochim. Biophys. Acta 437 (1976) 589-598
74. Vinograd J., Brunder R., Kent R., and Weigle J. Band-centrifugation of macromolecules and viruses in self-generating density gradient. Proc. Natl. Acad. Sci. USA 49 (1963) 902-910
75. Bowen T.J. An Introduction to Ultracentrifugation (1970), Wiley-Interscience, New York p. 50
76. Vinograd J. Sedimentation equilibrium in a buoyant density gradient. Methods Enzymol. 6 (1963) 854-870
77. Rux J.J., and Burnett R.M. Adenovirus structure. Hum. Gene Ther. 15 (2004) 1167-1176
78. Ifft J.B. Proteins in density gradients at sedimentation equilibrium. Methods Enzymol. 27 (1973) 128-140
79. Ifft J.B. Sedimentation equilibrium of proteins in density gradients. Biophys. Chem. 5 (1976) 137-157
80. Kohler K. Gewinnung und reiningung von adenovirus-typ 2 mit hilfe der CsCl-gradientenzentrifugation. Z. Naturforsch. 17b (1962) 544-547
81. E. Norrby, M. Gronberg, P. Magnusson, Virus-specific products appearing during the multiplication of adenovirus type 3, Unio Nordica Contra Cancrum (Symposium: Virus and Cancer), 1964, pp. 118-124.
82. Smith K.O. Studies on adenovirus type 12 I. Quantitative correlations between some physical, antigenic and infectious properties. J. Immunol. 94 (1965) 976-989
83. Shimojo H., Yamashita T., Yamamoto H., Suzuki E., and Abe C. Empty particles of adenovirus type 12. Jpn. J. Med. Sci. Biol. 20 (1967) 199-203
84. Wadell G., and Skaaret P. Separation of adenovirus type 14 components. Arch. Gesamte Virusforsch. 21 (1967) 366-382
85. Maizel Jr. J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus II. Soluble proteins, core, top components and the structure of the virion. Virology 36 (1968) 126-136
86. Vinograd J., and Bruner R. Band centrifugation of macromolecules in self-generating density gradient. III. Conditions for convection-free band sedimentation. Biopolymers 4 (1966) 157-170
87. Vinograd J., and Bruner R. Band centrifugation of macromolecules in self-generation density gradient. II. Sedimentation and diffusion of macromolecules in bands. Biopolymers 4 (1966) 131-156
88. Prage L., Hoglund S., and Philipson L. Structural proteins of adenovirus VIII. Characterization of incomplete particles of adenovirus type 3. Virology 49 (1972) 745-757
89. Wadell G., Hammarskjold M.-L., and Varsanyi T. Incomplete virus particles of adenovirus type 16. J. Gen. Virol. 20 (1973) 287-302
90. Ishibashi M., and Maizel Jr. J.V. The polypeptides of adenovirus V. Young virions, structural intermediate between top components and aged. Virology 57 (1974) 409-424
91. D'Halluin J.-C., Milleville M., Boulanger P.A., and Martin G.R. Temperature-sensitive mutants of adenovirus type 2 blocked in virion assembly: accumulation of light intermediate particles. J. Virol. 26 (1978) 344-356
92. D'Halluin J.-C., Martin G.R., Torpier G., and Boulanger P.A. Adenovirus type 2 assembly analyzed be reversible cross-linking of labile intermediate. J. Virol. 26 (1978) 357-363
93. Sutjipto S., Ravindran S., Cornell D., Lui Y.-H., Horn M., Schluep T., Hutchins B., and Vellekamp G. Characterization of empty capsids from a conditionally replicating adenovirus for gene therapy. Hum. Gene Ther. 16 (2005) 109-125
94. Bowen T.J. An Introduction to Ultracentrifugation (1970), Wiley-Interscience, New York pp. 15-30
95. Schachman H.K. Ultracentrifugation in Biochemistry (1959), Academic Press, New York pp. 32-50
96. Creeth J.M., and Pain R.H. The determination of molecular weights of biological macromolecules by ultracentrifugation methods. Prog. Biophys. Mol. Biol. 17 (1967) 217-287
97. R.A. Gray, A. Stern, T. Bewley, S.J. Shire, Rapid determination of spectrophotometric absorptivity by analytical ultracentrifugation, Application information #A-1815A, Beckman/Coulter.
98. Yphantis D.A., Lary J.W., Stafford W.F., Liu S., Olsen P.H., Hayes D.B., Moody T.P., Ridgeway T.M., Lyons D.A., and Laue T.M. On-line data acquisition for the Interference optical system of the analytical ultracentrifuge. In: Schuster T.M., and Laue T.M. (Eds). Modern Analytical Ultracentrifuge (1994), Birkhauser, Boston 209-226
99. A. Balbo, P. Schuck, Analytical ultracentrifugation in the study of protein self-association and heterogeneous protein-protein interactions, in: G. Olemis, P.D. Adams (Eds.), Protein-Protein Interactions, Cold Spring Laboratory Press, Cold Spring Harbor, NY, 2005, in press. Also available at .
100. Van Oostrum J., and Burnett R.M. Molecular composition of the adenovirus type 2 virion. J. Virol. 56 (1985) 439-448
101. Stewart P.L., and Burnett R.N. Adenovirus structure by X-ray crystallography and electron microscopy. Curr. Top. Microbiol. Immunol. 199 (1993) 25-38
102. Stewart P.L., Burnett R.M., Cyrklaff M., and Fuller S.D. Image reconstruction reveal the complex molecular organization of adenovirus. Cell 67 (1991) 145-154
103. Garcia De La Torre J., and Bloomfield V.A. Hydrodynamic properties of complex, rigid biological macromolecules: theory and applications. Q. Rev. Biophys. 14 (1981) 81-139
104. Camerini-Otero R.D., Pusey P.N., Koppel D.E., Schaefer D.W., and Franklin R.M. Intensity fluctuation spectroscopy of laser light scattered by solutions of spherical viruses: R17, Qβ, BSV, PM2, and T7. II. Diffusion coefficients, molecular weights, solvation, and particle dimension. Biochemistry 13 (1974) 960-970
105. Toth M., Tarodi B., and Beladi I. Preparative separation of intact incomplete and empty adenovirus type 2 particles. Acta Virol. 26 (1982) 217-220
106. Edvardsson B., Everitt E., Jornvall H., Page L., and Philipson L. Intermediates in adenovirus assembly. J. Virol. 19 (1979) 533-547
107. D'Halluin J.-C. Virus assembly. In: Doerfler W., and Bohm P. (Eds). The Molecular Repertoire of Adenovirus I-virion Structure and Infection (1995), Springer-Verlag, Berlin, Germany 47-66
108. See for example the characterization data for the Adenovirus Type 5 Reference Material distributed by the ATCC, available as .
109. Stewart P.L., Fuller S.D., and Burnett R.M. Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 12 (1993) 2589-2599
110. Green M., and Pina M. Biochemical studies on adenovirus multiplication. VI. Properties of highly purified tumorigenic human adenovirus. Proc. Natl. Acad. Sci. USA 51 (1964) 1251-1259
111. Roberts R.J., O'Neill K.E., and Yen C.T. DNA sequences from the adenovirus 2 genome. J. Biol. Chem. 259 (1984) 13968-13975
112. Davison A.J., Benko M., and Harrach B. Genetic content and evolution of adenoviruses. J. Gen. Virol. 84 (2003) 2895-2908
113. Sugarman B.J., Hutchins B.M., Mcallister D.L., Lu F., and Thomas K.B. The complete nucleic acid sequence of the adenovirus type 5 reference material (ARM) genome. BioProcess J. 2 (2003) 27-32
114. Sweeney J.A., and Henessey Jr. J.P. Evaluation of the accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption. Virology 295 (2002) 284-288
115. Philo J.S. Is any measurement method optimal for all aggregate sizes and types?. AAPS J. 8 (2006) E564-E571
116. Liu J., Andya J.D., and Shire S.J. A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation. AAPS J. 8 (2006) E580-E589
117. Kratochvil P. Particle scattering functions. In: Huglin M.B. (Ed). Light Scattering from Polymer Solutions (1972), Academic Press 333-384
118. Bloomfield V.A. Static and dynamic light scattering from aggregating particles. Biopolymers 94 (2000) 168-172
119. Tabor B.E. Preparation and clarification of solutions. In: Huglin M.B. (Ed). Light Scattering from Polymer Solutions (1972), Academic Press 1-25
120. Provencher S.W. Inverse problem in polymer characterization: direct analysis of polydispersity with photon correlation spectroscopy. Makromol. Chem. 180 (1979) 201-209
121. Demeester J., De Smedt S.S., Sanders N.N., and Haustraete J. Light scattering. In: Jiskoot W., and Crommelin D. (Eds). Methods for Structural Analysis of Protein Pharmaceuticals (2005), AAPS Press 245-275
122. Takahashi E., Cohen S.L., Tsai P.K., and Sweeney J.A. Quantitation of adenovirus type 5 empty capsid. Anal. Biochem. 349 (2006) 208-217
123. Vellekamp G., Ravindran S., Lin M., Sluzky V., and Lehmberg E. A contaminate in the adenovirus reference material. BioProcessing J. 1 (2002) 57-61
124. Mittereder N., March K.L., and Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70 (1996) 7498-7509
125. Schuck P. A model for sedimentation in inhomogeneous media. I. Dynamic density gradient from sedimenting co-solutes. Biophys. J. 108 (2004) 187-200
126. Green M., Pina M., Kimes R., Wensink P.C., MacHattie L.A., and Thomas Jr. C.A. Adenovirus DNA, I. Molecular weight and conformation. Proc. Natl. Acad. Sci. USA 57 (1967) 1302-1309
127. Huglin M.B. Specific refractive index increments. In: Huglin M.B. (Ed). Light Scattering from Polymer Solutions (1972), Academic Press 165-203
128. Cohen G., and Eisenberg H. Deoxyribonucleate solutions: sedimentation in a density gradient, partial specific volumes, density and refractive increments and preferential interactions. Biopolymers 6 (1968) 1077-1100
129. Krasna A.I. Low-angle light-scattering studies on alkali- and heat-denatured DNA. Biopolymers 9 (1970) 1029-1038
130. Pearlmann G.E., and Longworth L.G. The specific refractive increment of some purified proteins. J. Am. Chem. Soc. 70 (1948) 2719-2724
131. Camerini-Otero R.D., Franklin R.M., and Day L.A. Molecular weights, dispersion of refractive index increment, and dimensions form transmittance spectrophotometry. Bacteriophages R17, T7, and PM2 and tobacco mosaic virus. Biochemistry 13 (1974) 3763-3773
132. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acids sequence data. Anal. Biochem. 182 (1989) 318-326
133. Mach H., Middaugh C.R., and Lewis R.V. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal. Biochem. 200 (1992) 74-80
134. Pace C.N., Vajdos F., Fee L., Grimsley G., and Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4 (1995) 2411-2423